drugset / Trial / NCT01536873
Dolutegravir Expanded Access Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
ING114916 is an open-label, multi-center, expanded access (EAP) study
Timeline
- Start
- 2012-06-14
- Primary completion
- 2016-09-23
- Completion
- 2016-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dolutegravir | Other / unclassified | 50 mg | Oral |